1 |
Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, et al. Corticotropin releasing factor receptor 1-deficient micedisplay decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 1998;20(6):1093-102.
DOI
ScienceOn
|
2 |
Porsolt RD. Animal model of depression. Biomedicine 1979;30:139-140.
|
3 |
Arai N, Isaji M, Kojima M, Mizuta E, Kuno S. Combined effects of cabergoline and L-dopa on parkinsonism in MPTP-treated cynomolgus monkeys. J Neural Transmission 103(11):1037-1316, 1996.
|
4 |
Lau, Y.S., Meredith, G.E. From drugs of abuse to parkinsonism: The MPTP Mouse Model of Parkinson's Disease. Methods in Molecular Medicine 79(1): 103-116, 2003.
|
5 |
Lee JM. Dongeuisoosebowonsasangbonchokwon. Seoul: Eulyumoonhwasa. 2002:27-278. (Korean)
|
6 |
The National College of Oriental Medicine Sasangeuihakclassroom. Sasangeuihak. Seoul: Jipmundang. 2004: 260,265,276,394-5,442-80. (Korean)
|
7 |
Song IB et all. Sasangeuihak. Seoul:Jipmundang. 2004:343,366. (Korean)
|
8 |
Lee JC. Sinsasangeuihakron II. Seoul:Mokkwato. 2001:79-83. (Korean)
|
9 |
Jeong BJ, Kim JW, Kim BC, Woo SH, Na YJ, Shin HJ et al. A case of tremor in Parkinson's disease treated with Korean medicine. Korean J. Orient.int.Med. 2006:27(4)954-961. (Korean)
|
10 |
Bae NY. Neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement on Parkinsonian model. Dae-jeon National University. 2013;25(3):208-217. (Korean)
|
11 |
Brian R. Perri, Douglas H. Smith, Hisayuki Murai, Grant Sinson, Kathryn E. Saatman, Ramesh Raghupathl, Raymond T. Bartus, Tracy K. Mcintosh. Metabolic Quantification of Lesion Volume following Experimental Traumatic Brain Injury in the Rat. Journal of Neurotrauma. 1997;14:15-22.
DOI
ScienceOn
|
12 |
Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39:889-909.
DOI
ScienceOn
|
13 |
Imaki T, Katsumata H, Miyata M, Naruse M, Imaki J, Minami S. Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress. Neuroendocrinology. 2001;73(5):293-301.
DOI
ScienceOn
|
14 |
Bae NY, Yang HO, Ahn TW. Protection effect of New-Yeolda-Hanso tang -Amyloid Induced Cytotoxicity in NGF-differentiated PC12 Cells. J Sasang Constitut Med. 2009;21:138-153. (Korean)
과학기술학회마을
|
15 |
Bae NY, Ahn TK, Chung SK, Oh MS, Ko HS, Oh HG et al. The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in modelsof Parkinson's disease. Journal of Ethnopharmacology. 2011;134:313-322. (Korean)
DOI
ScienceOn
|
16 |
Seo JH, Shin MS, Kim CJ, Lee KS, lim BB. The influence of treadmill exercise in hot environments about serotonin expression in the rat brain, generating neurons and short-term memory. Korean Journal of Sport Science. 2009;20(4);744. (Korean)
|
17 |
Ferger, B., Teismann, P., Earl, C,D., Kuschinsky, K., Oertel, W.H. The propective effects of PBN against MPTP toxocity are independent of hydroxyl radical trapping. Phamaco Biochem Behav. 2000;65(3): 425-431.
DOI
ScienceOn
|
18 |
Vosselera M., N. Abegunewardenea, N. Hoffmannb, S.E. Petersene, D. Beckera, D. Cleppienb, P. Kunzc, K.-F. Kreitnerc, M. Lauterbacha, B. Bierbachd, C. Duberc, T. Goria, T. Munzela, L.M. Schreiberb, G. Horsticka. Area at Risk and Viability after Myocardial Ischemia and Reperfusion Can Be Determined by Contrast-Enhanced Cardiac Magnetic Resonance Imaging. Eur Surg Res. 2009;43:13-23.
DOI
ScienceOn
|
19 |
Widdowson, P.S., Farnworth, M.J., Upton, R., Simpson, M.G. No changes in behavior, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rat. Human and Experomental Toxicology. 1996; 15(7):583-591.
DOI
ScienceOn
|
20 |
Westm B.D., Sheghrue, P.J., Vanko, A.E.H,, Ransorn, R.W. Kinney, G.G. Amphetamine-induced locomotor activity is reduced in mice following MPTP treatment but not following selegiline/MPTP treatment. Pharmacol. Biochm. Behav 2006;84(1):158-161.
DOI
|
21 |
Sun, L., Xu, S., Zhou, M., Wang, C., Wu, Y., Chan, P. Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice. Brain Research. 2010;1335:74-82.
DOI
|
22 |
Fetoni V, Soliveri P, Monza D, Testa D, Girotti F. Affective symptoms in multiple system atropy and Parkinson's disease : response to levodopa therapy. J Neurol Neurosurg Psychiatry. 1999;66:541-544.
DOI
|
23 |
Burn DJ. Depression in Parkinson's disease. Eur J Neurol 9. 2002:44-54.
DOI
|
24 |
Porsolt RD, Anton G, Blavet N et al. Behavioral despair in rats : A new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47:379-391.
DOI
ScienceOn
|
25 |
Langston, J.W., Irwin, I., Langston, E.B., Forno, L.S. Pargyline prevents MPTP-induced parkinsonism in primates. Science 225(4669):1460-1462, 1984.
DOI
|
26 |
Cummings JL. Depression in Parkinson's disease : a review. Am J Psychiatry 1992;149:443-454.
DOI
|
27 |
Kasper, Braunwald, Fauci, Hauser, Longo, Jameson. Harrison's Principles of Internal medicine. 16th edition. Seoul: MIP. 2006:2631-2638.
|